“Someone special at St. Jude would like to say hello,” this is what Guests at Chili’s® Grill & Bar Highland Springs restaurant heard after choosing to donate to St. Jude Children’s Research Hospital® during this year’s Create-A-Pepper campaign. It’s often difficult to connect how an add-on donation at the end of a meal or coloring a pepper while at Chili’s can have an impact on the kids at St. Jude, but over the past 15 years, each donation and pepper has added up to more than $64 million to support St. Jude’s mission of Finding cures. Saving children®.
This year, Chili’s is showing how a little action can create a big impact by continuing to connect those who care with those in need of care. ChiliHeads at Highland Springs in Beaumont, Calif. surprised everyday Guests with a special thank you for their donation to St. Jude. Guests came in expecting a normal dining experience and got something completely different. After a donation, Guests received a video call from a St. Jude survivor who personally shared their story and the difference each donation makes in ensuring that no family ever receives a bill.
To view the multimedia release go to:
https://www.multivu.com/players/English/8227251-chilis-st-jude-create-a-pepper/
In an effort to improve outcomes for patients with some of the deadliest childhood cancers, St. Jude Children’s Research Hospital scientists have created the world’s largest collection of pediatric solid tumor samples, drug-sensitivity data and related information and have made the resource available at no charge to the global scientific community.
St. Jude and the Howard Hughes Medical Institute collaborated to create the resource, known as the Childhood Solid Tumor Network. The work is reported today as an advance online publication in the scientific journal Nature.
“Survival rates for children with recurrent solid tumors have not improved significantly in more than 20 years and remain below 30 percent,” said corresponding author Michael Dyer, Ph.D., chair of the St. Jude Department of Developmental Neurobiology and a Howard Hughes Medical Institute investigator. “This research will change that by promoting scientific collaboration to leverage the efforts of researchers worldwide to advance understanding and ultimately treatment of pediatric solid tumors.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8121952-st-jude-childrens-childhood-solid-tumor-network/
Summit Homes, a Berkshire Hathaway subsidiary through Clayton Properties Group, presented St. Jude Children’s Research Hospital representatives a check for $718,000 following the sale of the builder’s 2017 St. Jude Dream Home Showplace.
Summit Homes, the largest new home builder in Kansas City, built the 2017 St. Jude Dream Home Showplace as an extension of the St. Jude Dream Home® Giveaway Program, to support children battling cancer and other catastrophic diseases. The builder pledged 100% of proceeds from the sale of the home to as a donation for the research hospital.
To view the multimedia release go to:
https://www.multivu.com/players/English/8011654-clayton-summit-homes-st-jude-dream-home-2017/
Changes in the treatment of pediatric cancer over recent decades have translated to a reduced risk of serious, long-term late health effects of cancer therapy. This is according to the latest analysis from the Childhood Cancer Survivor Study (CCSS), a National Cancer Institute-funded resource for late-effects research, led by investigators at St. Jude Children’s Research Hospital.
“This is the first comprehensive study to demonstrate how changes in treatments over time have impacted the occurrence of late effects experienced by childhood cancer survivors,” said Todd Gibson, Ph.D., assistant member of the Department of Epidemiology and Cancer Control at St. Jude. “We found the 15-year cumulative incidence of people reporting at least one severe health condition decreased from 12.7 percent among childhood cancer survivors diagnosed in the 1970s to 10.1 percent for those diagnosed in the 1980s to 8.8 percent in the 1990s–a statistically significant decline.”
To view the multimedia release go to:
https://www.multivu.com/players/English/7924756-st-jude-childhood-cancer-survivorship-asco-2017/
St. Jude Children’s Research Hospital patients who completed kindergarten during their treatment for pediatric cancers celebrated at a graduation ceremony.
For the 10th straight year, St. Jude honored 14 patients from around the United States who completed kindergarten while battling life-threatening illnesses like leukemia and brain tumors. Dozens of families and St. Jude doctors, nurses, and staff cheered for the young students, who completed kindergarten in the St. Jude School Program by Chili’s.
Each year, the school program commemorates students who have completed kindergarten coursework with a special ceremony. The children present a song for the families and St. Jude staff, receive their diplomas and celebrate the milestone with their fellow students.
To view the multimedia release go to:
https://www.multivu.com/players/English/7924755-st-jude-celebrates-kindergarten-graduation/
St. Jude Children’s Research Hospital is naming the institution’s principal research tower after Donald Pinkel, M.D., whose legacy of driving progress toward advancing cures for pediatric catastrophic diseases continues at the institution today.
When St. Jude was established 55 years ago, Pinkel, the hospital’s first medical director, committed to finding cures for childhood cancer, leading to groundbreaking treatments that saved countless children’s lives. Many of these cancers were deemed incurable prior to Pinkel’s research, but his distinct approach to eradicating diseases established a model for how cancers could be treated.
To view the multimedia release go to:
https://www.multivu.com/players/English/7924752-st-jude-childrens-research-hospital-donald-pinkel-tower/
St. Jude Children’s Research Hospital® will celebrate its 14th annual FedEx/St. Jude Angels and Stars Gala, by welcoming back model and television personality, as well as co-founder, Daisy Fuentes, for an evening of fine dining and Latin music at 6:30 p.m. on Saturday, May 14, at the Intercontinental Hotel in downtown Miami. The annual event raises funds to help ensure families never receive a bill from St. Jude for treatment, travel, housing or food – because all a family should worry about is helping their child live.
Cuban-born American journalist and one of Time magazine’s “25 Most Influential Hispanics in America,” Cristina Saralegui, will be recognized for her commitment to giving back and educating the Hispanic community. “Being recognized by St. Jude Children’s Research Hospital is a true honor. Lending my voice to matters that touch my heart is what’s it’s all about. These children need our help and they need your help,” said Saralegui.
To view the multimedia release go to:
http://www.multivu.com/players/English/7758751-st-jude-angels-stars-gala/
Adolescents and young adults with a severe inherited immunodeficiency disorder improved following treatment with novel gene therapy developed at St. Jude Children’s Research Hospital and at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The results of this study appear today in the journal Science Translational Medicine.
The study involved five males with X-linked severe combined immunodeficiency disease (SCID-X1), also known as “Bubble Boy” disease, who were all treated at NIAID. This inherited disorder involves a mutation in the IL2RG gene that affects males and occurs in 1 of every 50,000 to 100,000 live births, leaving them with little to no immune protection.
To view the multimedia release go to:
http://www.multivu.com/players/English/7808651-st-jude-gene-therapy-results/
When it comes to St. Jude Children’s Research Hospital®, you don’t have to fly, have superhuman strength or have laser vision to be a Hero. St. Jude Heroes are an exclusive group of dedicated athletes committed to running for a reason—raising funds and awareness to support the lifesaving mission of St. Jude Children's Research Hospital.
St. Jude Heroes receive fundraising tools and support, along with event-specific benefits. More importantly, they help kids diagnosed with cancer and other life-threatening diseases. Thanks to dedicated St. Jude Heroes and other supporters, families never receive a bill from St. Jude for treatment, travel, housing or food — because all a family should worry about is helping their child live.
St. Jude Children’s Research Hospital founder Danny Thomas once said, “Success has nothing to do with what you gain in life or accomplish for yourself. It's what you do for others.” This statement couldn’t be more accurate of St. Jude Heroes.
To view the multimedia release go to:
http://www.multivu.com/players/English/7579851-st-jude-rock-n-roll-nashville-marathon/
St. Jude Children’s Research Hospital® officials and guests today marked the opening of the St. Jude Red Frog Events Proton Therapy Center, the first proton therapy center in the world dedicated solely to children with cancer.
Patients are now being treated at the center using precisely delivered, high-energy particles called protons to kill or shrink tumors while minimizing damage to healthy tissue and organs. For patients with brain tumors and certain other cancers, research suggests proton beam therapy may be more effective than conventional radiation at preventing the growth and spread of tumors while reducing the risk of treatment-related side effects.
To view the multimedia release go to:
http://www.multivu.com/players/English/7713451-st-jude-proton-therapy-opening/
The most detailed analysis yet of the role germline mutations in genes associated with cancer predisposition play in the development of childhood cancer suggests that comprehensive genomic screening may be warranted on all pediatric cancer patients, not just those with a family history of cancer. The study from the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project appears in the November 19 edition of the New England Journal of Medicine.
Ultimately, researchers anticipate that systematic monitoring of patients and family members who have germline mutations in cancer predisposition genes will allow the detection of cancers at their earliest and most curable stage, thereby improving the outcomes for these children and family members.
To view the multimedia release go to:
http://www.multivu.com/players/English/7692851-st-jude-hospital-genome-project/
